These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21476913)

  • 1. Fibrogenesis in nonalcoholic steatohepatitis.
    De Minicis S; Svegliati-Baroni G
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):179-87. PubMed ID: 21476913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
    Gambino R; Musso G; Cassader M
    Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis.
    Rombouts K; Marra F
    Dig Dis; 2010; 28(1):229-35. PubMed ID: 20460917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J; Choi SS; Diehl AM
    Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fibrogenesis and metabolic factors.
    Anty R; Lemoine M
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S10-20. PubMed ID: 21742296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in nonalcoholic steatohepatitis.
    Harmon RC; Tiniakos DG; Argo CK
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):189-200. PubMed ID: 21476914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
    Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
    Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis.
    van der Poorten D; George J
    Clin Liver Dis; 2008 Nov; 12(4):805-24, ix. PubMed ID: 18984468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and fibrogenesis in steatohepatitis.
    Fujii H; Kawada N
    J Gastroenterol; 2012 Mar; 47(3):215-25. PubMed ID: 22310735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
    Spahr L; Rubbia-Brandt L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adipocytokines in hepatic fibrogenesis.
    Ikejima K; Okumura K; Kon K; Takei Y; Sato N
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S87-92. PubMed ID: 17567476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
    Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
    Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis.
    Kisseleva T; Brenner DA
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S73-8. PubMed ID: 17567473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
    Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
    Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of liver fibrosis by adipokines.
    Marra F; Navari N; Vivoli E; Galastri S; Provenzano A
    Dig Dis; 2011; 29(4):371-6. PubMed ID: 21894007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin A in nonalcoholic fatty liver disease.
    Yndestad A; Haukeland JW; Dahl TB; Halvorsen B; Aukrust P
    Vitam Horm; 2011; 85():323-42. PubMed ID: 21353887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis.
    Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():44-7. PubMed ID: 16225472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.
    Washington K; Wright K; Shyr Y; Hunter EB; Olson S; Raiford DS
    Hum Pathol; 2000 Jul; 31(7):822-8. PubMed ID: 10923919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.